HEP DART 2017

HEPDART GROUP PHOTO

Thank you to all Faculty members and delegates who participated in this year's HEP DART, which was held from December 3rd-7th, 2017. 

We look back at a very successful meeting with key speakers, exciting lectures, and great oral abstract presentations. We hope you enjoyed the event as much as we did, in beautiful Kona, Hawaii!

We would like to thank our sponsors once more, as this meeting would not have been possible without them:

Abbvie, Arbutus Biopharma, Emory University, Gilead, Janssen, the Raymond F. Schinazi & Family Foundation, W.H. Prusoff Foundation, Chiatai Tianqing Pharmaceutical Group, The Blatt Family Foundation, Galmed Pharmaceuticals, and The Hepatitis B Foundation.

An additional thank you to our contributors: Arrowhead Pharmaceuticals, Contrivir Pharmaceuticals Inc. and ST. Pharm Co., plus our meeting partners Erasmus Medical Center, and the International Symposium on HIV and Emerging Infectious Diseases. Your support has been invaluable.

Presentations
The presentations have been published (given that the speaker granted their permission and/or has sent their modified version) on our website Infectious Diseases Online.

The abstracts can also be found on this website.

Again, we thank you for your contribution and attendance. We hope to see you again at HEP DART 2019!

The Program Chairs,

Raymond Schinazi, PhD, DSC, and Charles Boucher, MD, PhD